Just Released: "Meningitis Preventive Vaccines - Pipeline Analysis and Market Forecasts to 2017"

Oct. 23, 2010 - PRLog -- GlobalData, the industry analysis specialist, has released its new report, "Meningitis Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Meningitis Preventive Vaccines market. The report identifies the key trends shaping and driving the global Meningitis Preventive Vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Meningitis Preventive Vaccines sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData has estimated the global Meningitis Preventive Vaccines market to be valued at $1.8 billion in 2009. It is expected to increase to $4.5 billion with a Compound Annual Growth Rate (CAGR) of (12%)by 2017. The market structure is projected to change in the near future following the entrance of new blockbuster products till 2017. Menveo Iis expected to come in the market by 2011 and Novartis menB vaccine by 2014 in US. There is a low unmet need in the current Meningitis Preventive Vaccines market in terms of both safety and efficacy profile

Scope

The report provides information on the key drivers and challenges of the Alzheimer's disease market. Its scope includes:

* Annualized global Meningitis Preventive Vaccines market revenues data from 2001 to 2009, forecast for eight years to 2017.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major vaccine classes such as of conjugate vaccine, recombinant vaccine and antigen vaccine.
* Analysis of the current and future competition in the global Meningitis Preventive Vaccines market. Key market players covered are Sanofi Pasteur, Merck & Co., Novartis, GSK.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Meningitis Preventive Vaccines market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Meningitis Preventive Vaccines market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Meningitis Preventive Vaccines market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Meningitis Preventive Vaccines market landscape? - Identify, understand and capitalize.

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/89217_meningitis_preventive_va...

Partial Table of Contents:

1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Meningitis: Introduction 6
2.1 GlobalData Pipeline Report Guide 7
3 Meningitis: Market Characterization 8
3.1 Meningitis Market Size 8
3.2 Meningitis Preventive Market Forecast and CAGR 9
3.3 Drivers and Barriers for the Meningitis Market 10
3.3.1 Drivers for Meningitis Market 10
3.3.2 Barriers for Meningitis Preventive Market 11
3.4 Opportunity and Unmet Need 11
3.5 Key Takeaway 12
4 Meningitis Market: Competitive Assessment 13
4.1 Overview 13
4.2 Strategic Competitor Assessment 13
4.3 Product Profiles for the Major Marketed Products in the Meningitis Preventive  Market 14
4.3.1 Menactra 14
4.3.2 ActHIB 15
4.3.3 Neisvac C- 15
4.4 Major Marketed Products Comparison in Meningitis Preventive Market 17
4.5 Key Takeaway 17
5 Meningitis Market: Pipeline Assessment 18
5.1 Technology Trends Analytical Framework 18
5.1.1 Overview 18
5.1.2 Strategic Pipeline Assessment 18
5.2 Meningitis - Promising Vaccines/Drugs Under Clinical Development 20
5.3 Molecule Profile for Promising Vaccines/Drugs Under Clinical Development 21
5.3.1 Menveo 21
5.3.2 Meningitis B Vaccine (MenB Vaccine) 21
5.4 Meningitis Market - Clinical Pipeline by Vaccine Class 22
5.5 Meningitis Pipeline - Pipeline by Clinical Phases of Development 23
5.5.1 Meningitis - Phase III Clinical Pipeline 23
5.5.2 Meningitis - Phase I Clinical Pipeline 25
5.5.3 Meningitis - Discovery and Preclinical Pipeline 25
5.6 Key Takeaway 25
6 Meningitis Preventive Market: Implications for the Future Market Competition 26
7 Global Meningitis Preventive Market: Future Players in Meningitis Market 27
7.1 Introduction 27
7.2 Novartis 27
7.2.1 Company Overview 27
7.2.2 Business Description 28
7.2.3 Novartis - Infectious Diseases Pipeline 29
7.2.4 Novartis - Meningitis Vaccines Pipeline 29
7.3 GlaxoSmithKline 30
7.3.1 Company Overview 30
7.3.2 Business Description 30
7.3.3 GlaxoSmithKline - Infectious Diseases Pipeline 31
7.3.4 GlaxoSmithKline - Meningitis Pipeline 32
7.4 Sanofi-aventis 32
7.4.1 Company Overview 32
7.4.2 Business Description 32
7.4.3 Sanofi-aventis Infectious Diseases Pipeline 33
7.4.4 Sanofi-aventis - Meningitis Pipeline 33
7.5 Merck & Co., Inc. 34

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=8921...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.